Last reviewed · How we verify
DESOXYRIBONUCLEASE
DESOXYRIBONUCLEASE is a drug. It is currently FDA-approved (first approved 1964).
At a glance
| Generic name | DESOXYRIBONUCLEASE |
|---|---|
| Modality | Enzyme |
| Phase | FDA-approved |
| First approval | 1964 |
Approved indications
Common side effects
Key clinical trials
- Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI) (PHASE1)
- Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection
- Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic (NA)
- Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas (NA)
- VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema (NA)
- Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema (PHASE4)
- Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections [LYTICS +] (PHASE2)
- I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DESOXYRIBONUCLEASE CI brief — competitive landscape report
- DESOXYRIBONUCLEASE updates RSS · CI watch RSS
Frequently asked questions about DESOXYRIBONUCLEASE
What is DESOXYRIBONUCLEASE?
DESOXYRIBONUCLEASE is a Enzyme drug.
When was DESOXYRIBONUCLEASE approved?
DESOXYRIBONUCLEASE was first approved on 1964.
What development phase is DESOXYRIBONUCLEASE in?
DESOXYRIBONUCLEASE is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing